China Regenerative Medicine International Ltd
HKEX:8592
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
HK |
|
C
|
Carpenter Tan Holdings Ltd
HKEX:837
|
CN |
|
CarrefourSA Carrefour Sabanci Ticaret Merkezi AS
IST:CRFSA.E
|
TR |
|
Hi-Tech Gears Ltd
NSE:HITECHGEAR
|
IN |
|
M
|
Moolec Science SA
NASDAQ:MLEC
|
LU |
|
Maha Energy AB
STO:MAHA A
|
SE |
|
Taiga Building Products Ltd
TSX:TBL
|
CA |
|
C
|
CCL Industries Inc
TSX:CCL.B
|
CA |
|
N
|
NDL Ventures Ltd
NSE:NDLVENTURE
|
IN |
|
eXp World Holdings Inc
NASDAQ:EXPI
|
US |
Bankruptcy Probability
China Regenerative Medicine International Ltd's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
China Regenerative Medicine International Ltd Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| HK |
C
|
China Regenerative Medicine International Ltd
HKEX:8158
|
77.6m HKD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
171.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
China Regenerative Medicine International Ltd's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, China Regenerative Medicine International Ltd has total debt of 64.4m HKD. This includes both short-term (0 HKD) and long-term (64.4m HKD) debt.
You can find a full breakdown on its Balance Sheet.
